4.5 Interaction with other medicinal products and other forms of interaction  
 No interaction studies have been performed. B ased on the biotransformation and elimination of faricimab (see section 5.2) , no int eractions are expected.  However, faricimab should not be administered concurrently with other systemic or ocular anti -VEGF medicinal products (see section 
4.4).  
 
